Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
612.50 INR | +1.83% |
|
+4.37% | +15.61% |
27/05 | Balrampur Chini Mills Limited launches `Balrampur Bioyug', India's first PLA Biopolymer Brand | CI |
16/05 | Balrampur Chini Mills Limited, Q4 2025 Earnings Call, May 16, 2025 |
Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.63 | 7.97 | 8.13 | 4.94 | 6.73 | |||||
Return on Total Capital | 9.36 | 9.7 | 9.46 | 5.6 | 7.61 | |||||
Return On Equity % | 22.91 | 19.06 | 17.24 | 10.03 | 16.98 | |||||
Return on Common Equity | 22.91 | 19.06 | 17.24 | 10.03 | 16.98 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 24.64 | 26.52 | 27.05 | 25.12 | 28.03 | |||||
SG&A Margin | 5.37 | 5.87 | 6.38 | 7.83 | 7.15 | |||||
EBITDA Margin % | 14.36 | 14.82 | 14.58 | 11.16 | 14.04 | |||||
EBITA Margin % | 12.24 | 12.51 | 12.24 | 8.4 | 11.08 | |||||
EBIT Margin % | 12.24 | 12.51 | 12.24 | 8.4 | 11.08 | |||||
Income From Continuing Operations Margin % | 10.95 | 9.97 | 9.59 | 6.09 | 9.55 | |||||
Net Income Margin % | 10.95 | 9.97 | 9.59 | 6.09 | 9.55 | |||||
Net Avail. For Common Margin % | 10.95 | 9.97 | 9.59 | 6.09 | 9.55 | |||||
Normalized Net Income Margin | 7.12 | 7.71 | 7.63 | 5.34 | 6.63 | |||||
Levered Free Cash Flow Margin | 7.62 | 7.56 | 3.48 | -12.04 | -6.05 | |||||
Unlevered Free Cash Flow Margin | 8.46 | 8.07 | 3.87 | -11.39 | -5.12 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1 | 1.02 | 1.06 | 0.94 | 0.97 | |||||
Fixed Assets Turnover | 3.06 | 2.96 | 2.81 | 2.09 | 2.11 | |||||
Receivables Turnover (Average Receivables) | 13.76 | 19.85 | 25.36 | 35.68 | 44.68 | |||||
Inventory Turnover (Average Inventory) | 1.55 | 1.51 | 1.54 | 1.55 | 1.55 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.46 | 1.63 | 1.6 | 1.31 | 1.43 | |||||
Quick Ratio | 0.3 | 0.2 | 0.09 | 0.1 | 0.06 | |||||
Operating Cash Flow to Current Liabilities | 0.43 | 0.38 | 0.47 | 0.23 | 0.08 | |||||
Days Sales Outstanding (Average Receivables) | 26.6 | 18.39 | 14.39 | 10.23 | 8.19 | |||||
Days Outstanding Inventory (Average Inventory) | 236.16 | 241.24 | 236.41 | 236.08 | 235.86 | |||||
Average Days Payable Outstanding | 65.74 | 63.69 | 47.34 | 30 | 23.77 | |||||
Cash Conversion Cycle (Average Days) | 197.01 | 195.94 | 203.46 | 216.31 | 220.28 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 61.37 | 47.36 | 43.71 | 64.91 | 59.08 | |||||
Total Debt / Total Capital | 38.03 | 32.14 | 30.42 | 39.36 | 37.14 | |||||
LT Debt/Equity | 14.09 | 9.29 | 5.24 | 14.84 | 9.62 | |||||
Long-Term Debt / Total Capital | 8.73 | 6.3 | 3.65 | 9 | 6.05 | |||||
Total Liabilities / Total Assets | 49.74 | 43.48 | 38.34 | 46.66 | 44.12 | |||||
EBIT / Interest Expense | 9.1 | 15.47 | 19.67 | 8.09 | 7.44 | |||||
EBITDA / Interest Expense | 10.68 | 18.34 | 23.43 | 10.76 | 9.43 | |||||
(EBITDA - Capex) / Interest Expense | 6.69 | 15.75 | 10.03 | -6.91 | 6.21 | |||||
Total Debt / EBITDA | 2.18 | 1.74 | 1.71 | 3.61 | 2.56 | |||||
Net Debt / EBITDA | 2.17 | 1.74 | 1.71 | 3.49 | 2.56 | |||||
Total Debt / (EBITDA - Capex) | 3.47 | 2.02 | 4 | -5.61 | 3.89 | |||||
Net Debt / (EBITDA - Capex) | 3.46 | 2.02 | 4 | -5.43 | 3.89 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 10.63 | 1.48 | 0.71 | -3.72 | 19.89 | |||||
Gross Profit, 1 Yr. Growth % | 0.62 | 9.24 | 2.75 | -10.6 | 33.79 | |||||
EBITDA, 1 Yr. Growth % | -1.46 | 4.72 | -0.95 | -26.27 | 50.81 | |||||
EBITA, 1 Yr. Growth % | -2.65 | 3.69 | -1.44 | -33.92 | 58.1 | |||||
EBIT, 1 Yr. Growth % | -2.65 | 3.69 | -1.44 | -33.92 | 58.1 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -9.81 | -7.62 | -3.16 | -38.84 | 88.08 | |||||
Net Income, 1 Yr. Growth % | -9.81 | -7.62 | -3.16 | -38.84 | 88.08 | |||||
Normalized Net Income, 1 Yr. Growth % | -7.13 | 9.91 | -0.29 | -32.6 | 48.75 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -7.03 | -4.09 | -0.15 | -37.9 | 90.07 | |||||
Accounts Receivable, 1 Yr. Growth % | -46.81 | 2.58 | -44.3 | -8.7 | 0.6 | |||||
Inventory, 1 Yr. Growth % | -0.91 | 3.63 | -7.48 | 5.37 | 23.75 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 11.58 | -1.43 | 13.94 | 42.75 | 2.36 | |||||
Total Assets, 1 Yr. Growth % | 2.23 | -3.6 | -3.06 | 20.85 | 12.11 | |||||
Tangible Book Value, 1 Yr. Growth % | 14.11 | 8.43 | 5.74 | 4.56 | 17.45 | |||||
Common Equity, 1 Yr. Growth % | 14.07 | 8.42 | 5.75 | 4.54 | 17.45 | |||||
Cash From Operations, 1 Yr. Growth % | -262.45 | -23.62 | 7 | -34.8 | -60.74 | |||||
Capital Expenditures, 1 Yr. Growth % | 94.79 | -60.35 | 300.63 | 111.86 | -68.61 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -147.05 | 0.67 | -53.64 | -433.02 | -39.75 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -154.02 | -3.27 | -51.69 | -383.38 | -46.12 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 0 | 0 | 0 | 20 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 4.49 | 5.96 | 1.1 | -1.53 | 7.44 | |||||
Gross Profit, 2 Yr. CAGR % | 24.73 | 4.84 | 5.94 | -4.16 | 9.36 | |||||
EBITDA, 2 Yr. CAGR % | 22.54 | 1.58 | 1.85 | -14.54 | 5.45 | |||||
EBITA, 2 Yr. CAGR % | 27.1 | 0.47 | 1.09 | -19.3 | 2.21 | |||||
EBIT, 2 Yr. CAGR % | 27.1 | 0.47 | 1.09 | -19.3 | 2.21 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 49.73 | -8.72 | -5.41 | -23.04 | 7.25 | |||||
Net Income, 2 Yr. CAGR % | 49.73 | -8.72 | -5.41 | -23.04 | 7.25 | |||||
Normalized Net Income, 2 Yr. CAGR % | 28.21 | 1.03 | 4.69 | -18.02 | 0.13 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 54.17 | -5.57 | -2.14 | -21.26 | 8.64 | |||||
Accounts Receivable, 2 Yr. CAGR % | 14.63 | -26.13 | -24.41 | -28.69 | -4.17 | |||||
Inventory, 2 Yr. CAGR % | 12.85 | 1.34 | -2.08 | -1.26 | 14.19 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 6.03 | 4.87 | 5.98 | 27.53 | 20.88 | |||||
Total Assets, 2 Yr. CAGR % | 13.99 | -0.73 | -3.33 | 8.23 | 16.4 | |||||
Tangible Book Value, 2 Yr. CAGR % | 22.28 | 11.23 | 7.08 | 5.15 | 10.82 | |||||
Common Equity, 2 Yr. CAGR % | 22.22 | 11.21 | 7.08 | 5.14 | 10.81 | |||||
Cash From Operations, 2 Yr. CAGR % | -15.14 | 11.39 | -9.58 | -16.48 | -49.4 | |||||
Capital Expenditures, 2 Yr. CAGR % | 36.91 | -12.12 | 26.04 | 191.34 | -18.44 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -39.18 | -31.18 | -31.69 | 24.25 | 41.62 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -36.95 | -27.71 | -31.64 | 17.01 | 23.54 | |||||
Dividend Per Share, 2 Yr. CAGR % | 0 | 0 | 0 | 0 | 9.54 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 11.07 | 3.48 | 4.18 | -0.53 | 5.15 | |||||
Gross Profit, 3 Yr. CAGR % | -2.59 | 19.34 | 4.14 | 0.11 | 7.11 | |||||
EBITDA, 3 Yr. CAGR % | -8.94 | 16.28 | 0.73 | -8.55 | 3.27 | |||||
EBITA, 3 Yr. CAGR % | -10.06 | 18.76 | -0.17 | -12.27 | 0.98 | |||||
EBIT, 3 Yr. CAGR % | -10.06 | 18.76 | -0.17 | -12.27 | 0.98 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -4.31 | 27.47 | -6.9 | -18.21 | 3.66 | |||||
Net Income, 3 Yr. CAGR % | -4.32 | 27.47 | -6.9 | -18.21 | 3.66 | |||||
Normalized Net Income, 3 Yr. CAGR % | -10.8 | 21.79 | 0.59 | -9.6 | -0.01 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -1.17 | 31.61 | -3.8 | -15.9 | 5.63 | |||||
Accounts Receivable, 3 Yr. CAGR % | 13.73 | 10.46 | -32.77 | -19.5 | -20.02 | |||||
Inventory, 3 Yr. CAGR % | -0.27 | 9.69 | -1.69 | 0.34 | 6.46 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 4.93 | 3.48 | 7.81 | 17.04 | 18.52 | |||||
Total Assets, 3 Yr. CAGR % | 6.07 | 7.79 | -1.51 | 4.14 | 9.51 | |||||
Tangible Book Value, 3 Yr. CAGR % | 15.73 | 17.48 | 9.37 | 6.23 | 9.1 | |||||
Common Equity, 3 Yr. CAGR % | 15.68 | 17.44 | 9.36 | 6.23 | 9.1 | |||||
Cash From Operations, 3 Yr. CAGR % | 34.96 | -18.07 | 9.92 | -18.92 | -35.06 | |||||
Capital Expenditures, 3 Yr. CAGR % | 25.22 | -9.42 | 45.72 | 49.86 | 38.64 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 261.82 | -28.06 | -39.67 | 15.83 | -2.4 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 146.96 | -27.28 | -36.8 | 9.81 | -9.66 | |||||
Dividend Per Share, 3 Yr. CAGR % | -10.61 | 0 | 0 | 0 | 6.27 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 9.68 | 11.78 | 6.97 | 1.45 | 5.47 | |||||
Gross Profit, 5 Yr. CAGR % | 22.23 | 11.53 | 0.74 | 9.32 | 6.2 | |||||
EBITDA, 5 Yr. CAGR % | 39.38 | 11.37 | -4.77 | 2.8 | 2.59 | |||||
EBITA, 5 Yr. CAGR % | 110.55 | 14.41 | -5.75 | 1.76 | 0.77 | |||||
EBIT, 5 Yr. CAGR % | 110.55 | 14.41 | -5.75 | 1.76 | 0.77 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 55.06 | 36.8 | -4.75 | 4.17 | -1.48 | |||||
Net Income, 5 Yr. CAGR % | 55.06 | 36.78 | -4.76 | 4.17 | -1.48 | |||||
Normalized Net Income, 5 Yr. CAGR % | 45.64 | 18.81 | -4.9 | 3.96 | 0.41 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 58.13 | 40.61 | -1.56 | 7.17 | 1 | |||||
Accounts Receivable, 5 Yr. CAGR % | 8.57 | 4.32 | -3.42 | -7.28 | -22.52 | |||||
Inventory, 5 Yr. CAGR % | 6.58 | 4.99 | -1 | 5.17 | 4.38 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 3.44 | 2.52 | 5.35 | 12.5 | 12.86 | |||||
Total Assets, 5 Yr. CAGR % | 4.25 | 4.6 | 2.21 | 7.97 | 5.29 | |||||
Tangible Book Value, 5 Yr. CAGR % | 16.53 | 16.38 | 12.19 | 12.38 | 9.95 | |||||
Common Equity, 5 Yr. CAGR % | 16.47 | 16.34 | 12.16 | 12.36 | 9.94 | |||||
Cash From Operations, 5 Yr. CAGR % | 61.93 | 34.58 | 14.98 | -17.43 | -19.41 | |||||
Capital Expenditures, 5 Yr. CAGR % | 56.64 | -8.02 | 25.54 | 44.54 | 15.53 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 15.63 | 17.16 | 85.74 | -10.48 | -15.13 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 29.23 | 25.74 | 47.74 | -12.04 | -17.37 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | -6.51 | 0 | 3.71 |
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition